Founded Year

2012

Stage

Unattributed VC | Alive

Total Raised

$2.08M

Last Raised

$2.08M | 6 yrs ago

About SpinChip Diagnostics

SpinChip Diagnostics develops in vitro point of care systems that use lab-on-a-chip technology for the diagnosis of cardiovascular, endocrine, anemic, diabetic, infectious ad inflammatory diseases.

SpinChip Diagnostics Headquarter Location

Forskningsveien 1

Oslo, 0373,

Norway

47 90 52 81 51

SpinChip Diagnostics's Product Videos

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

SpinChip Diagnostics's Products & Differentiation

See SpinChip Diagnostics's products and how their products differentiate from alternatives and competitors

  • Spinchip device and catridges

    Fully integrated in vitro diagnostic platform allowing performance of a broad spectrum of highly advanced analysis in PoC settings SpinChip’s unique dual axle centrifugation technology allowing extremely efficient and flexible microfluidic processing Two complementary readout systems including one high-sensitive Fluidic processing controlled and monitored by state-of-the-art vision system Suitable for emergency rooms, ambulances, doctor’s offices, in-field etc Fully self-contained cartridge with integrated sampler Both liquid and dried reagents are integrated in the cartridges Exterior shape is uniform for all assay cartridges Interior microfluidic designs are unique for each type of assay Fully automated process based on matrix code printed on the cartridge Potential for sampling other material - swab, feces, tissue/biops

    Differentiation

    lab equivalent performance (accurate, reliable), fast results, broad menu of tests on same device, flexible platform able to perform a multitude of test types and sample types 

Expert Collections containing SpinChip Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

SpinChip Diagnostics is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

8,395 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,095 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Diabetes

1,750 items

H

Health IT

7,900 items

SpinChip Diagnostics Patents

SpinChip Diagnostics has filed 5 patents.

The 3 most popular patent topics include:

  • Centrifuges
  • Blood
  • Engine components
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/19/2015

9/10/2019

Spectroscopy, Analytical chemistry, Molecular biology, Luminescence, Biotechnology

Grant

Application Date

6/19/2015

Grant Date

9/10/2019

Title

Related Topics

Spectroscopy, Analytical chemistry, Molecular biology, Luminescence, Biotechnology

Status

Grant

Latest SpinChip Diagnostics News

SpinChip® Secures NOK 130 million (€13.5 Million) in Financing Round

Jun 29, 2021

SpinChip® is now preparing for design verification and validation, CE-marking and market entry OSLO, Norway, June 29, 2021 (GLOBE NEWSWIRE) -- SpinChip Diagnostics AS, a pioneering, diagnostics company developing a next-generation point-of-care platform for in vitro diagnostics, today announced the completion of its financing round, successfully securing NOK 130 million (€13.5 million). Carnegie Investment Bank Norway  acted as Sole Bookrunner on SpinChip®’s NOK 130 million (€13.5 Million) private placement. Alongside new cornerstone investors such as Kistefos AS, the financing round was also well supported by existing shareholders. The proceeds from the financing round will be used to further advance SpinChip®’s proprietary point-of-care (POC) in vitro diagnostics platform in addition to establishing a pilot- and full-scale manufacturing plant to prepare for market entry. The SpinChip® proprietary diagnostics platform, consisting of the SpinChip® Analyser and assay-specific cartridges, is built on microfluidic technology in combination with nanotechnology-based cartridge assays. The platform is aimed at providing patients and healthcare professionals with a tool that only requires one droplet of blood to provide highly accurate results within minutes, next to the patient. The diagnostics platform has through internal trials already proven to match the most advanced high-sensitive laboratory diagnostic analysers, meaning it can contribute to faster reliable triaging and facilitate earlier onset of appropriate treatment of patients. SpinChip® is now preparing for clinical trial activities, including clinical performance studies, to gather sufficient data to apply for CE-marking, with its first diagnostic offering being within the acute cardiac segment. Morten Jurs, Chief Executive Officer of SpinChip Diagnostics AS, commented: “We are very pleased to have successfully completed the NOK 130 million private placement and are delighted to welcome several new investors to SpinChip®, alongside with strong support from existing shareholders. With this financial backing, we will be able to take the platform into the next stage of development to eventually apply for CE-marking whilst we are preparing for market entry.” Stig Morten Borch, Founder and Chief Scientific Officer of SpinChip Diagnostics AS, added: “SpinChip®’s platform represents the future of POC testing and we are delighted to get additional financial support to further advance the platform at this exciting time for the business.” Contact information:

SpinChip Diagnostics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

SpinChip Diagnostics Rank

  • When was SpinChip Diagnostics founded?

    SpinChip Diagnostics was founded in 2012.

  • Where is SpinChip Diagnostics's headquarters?

    SpinChip Diagnostics's headquarters is located at Forskningsveien 1, Oslo.

  • What is SpinChip Diagnostics's latest funding round?

    SpinChip Diagnostics's latest funding round is Unattributed VC.

  • How much did SpinChip Diagnostics raise?

    SpinChip Diagnostics raised a total of $2.08M.

  • Who are the investors of SpinChip Diagnostics?

    Investors of SpinChip Diagnostics include Investinor and Lars-Olof Hansson.

  • Who are SpinChip Diagnostics's competitors?

    Competitors of SpinChip Diagnostics include Siemens Healthineers and 1 more.

  • What products does SpinChip Diagnostics offer?

    SpinChip Diagnostics's products include Spinchip device and catridges.

You May Also Like

i
iAssay

iAssay is a provider of point of care diagnostics solutions. The company provides an open platform for wirelessly connected point of care (POC) diagnostics. The device aggregates test, patient, and wearables data and pushes all data into the cloud. The aim is to eliminate test result delays, delayed diagnosis, sample handling and transportation costs. It also aim to improve patient outcomes and save the healthcare system money.

Glassbeam Logo
Glassbeam

Glassbeam is the machine data analytics company. Bringing structure and meaning to data from any connected device, Glassbeam provides actionable intelligence around the Internet of Things. Glassbeam's next generation cloud-based analytics platform is designed to organize and analyze multi-structured data, delivering powerful product and customer intelligence for companies including IBM, HDS, Aruba Networks and Meru Networks.

Lucida Medical Logo
Lucida Medical

Lucida Medical enables healthcare professionals to find cancer quickly & efficiently with artificial intelligence (AI) and magnetic resonance imaging (MRI).

Medic Vision Logo
Medic Vision

Medic Vision specializes in universal add-on turnkey solutions for direct end-user applications and for incorporation by major CT and PACS manufacturers into existing platforms and product offerings.

D
Dignio

Dignio makes it possible for healthcare providers to offer a new remote care service to their patients. With its solution healthcare personnel can follow up on patients in a safe way, and at the same time giving patients both flexibility and a sense of achievement.

MicroX Labs Logo
MicroX Labs

MicroX Labs is developing a low-cost, portable, easy-to-use blood test device to measure the complete blood count of a person.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.